Homans Elizabeth 4
4 · Lyell Immunopharma, Inc. · Filed Mar 18, 2022
Insider Transaction Report
Form 4
Homans Elizabeth
DirectorChief Executive Officer
Transactions
- Award
Option (right to buy)
2022-03-16+1,479,500→ 1,479,500 totalExercise: $5.98Exp: 2032-03-15→ Common Stock (1,479,500 underlying)
Footnotes (1)
- [F1]12.5% of the option shares shall vest on August 9, 2022, with the remaining option shares to vest in equal monthly installments over the following forty-two months.